Anavex Life Sciences Corp (AVXL)

[falconer66a]

But then for other conditions?

Fragile X and secondarily Rett will be the data for seizure approval. ...that seizure reduction will be an endpoint.

That's very likely. Hope it works out that way.

But, if it does, could a physician then prescribe blarcamesine, off label, to obviate seizures in patients without Rett or Fragile X syndromes? That's the question with the wider implications for blarcamesine sales by Anavex.